Navigation Links
Optimizing electroporation parameters

Other important parameters for optimizing electroporation.
Adjustment of the electroporation buffer A precondition for successful electroporation with the Multiporator is the special buffer system with low electrical conductivity.

The best possible transfection results are obtained by using the original buffers from Eppendorf, which have been tested for sterility as well as for the absence of mycoplasma, endotoxins and pyrogens, and which have also under-gone a thorough cytotoxicity test.

Users may also make up this buffer themselves (see Table 1).

< TD vAlign=top align=middle>Eppendorf Isoosmolar Electroporation Buffer (PI) (no.: 4308 070.510)
Eppendorf Hypoosmolar Electroporation Buffer (PH) (no.: 4308 070.501)
Sterile bidistilled water Fill up to 1000 ml Fill up to 1000 ml
KCl 25 mM 25 mM
KH2PO4 0.3 mM 0.3 mM
K2HPO4 0.85 mM 0.85 mM
myo-Inositol* ad 90 mOsmol/kg ad 280 mOsmol/kg
pH value 7.2 0.1 7.2 0.1
Conductivity at 25C 3.5 mS/cm 10% 3.5 mS/cm 10%
Shelf-life 3 years 3 years
Table 1: Eppendorf Electroporation Buffer components

*The purity of myo-Inositol may vary greatly from batch to batch. It must be pure enough to ensure that, at 280 mOsmol/kg in bidistilled water, a conductivity of 10 S/cm is not exceeded. The conductivity of individual myo-Inositol batches should be measured before the preparation of the buffer.

Ideally, electroporation should be carried out in hypoosmolar buffer, in which the cell absorbs water shortly before the pulse and then swells up as a result. A number of effects, including a decreased optimal pulse voltage ensure that the plasma membrane can be permeated more easily.

For most cell types, the 2030-minute incubation period in hypoosmolar buffer has no effect on the viability of the cells. However, the incubation in hypoosmolar buffer may induce apoptosis, or even lysis, in very sensitive cells. Therefore, it is strongly recommended to test the tolerance of the cells to hypoosmolar conditions. The easiest way of doing so is by incubating the cells for 30 minutes in hypoosmolar buffer and then performing a viability stain using trypan blue or propidium iodide. If observation under a microscope reveals lysis in more than 10% of the cells, the osmolarity of the buffer must be increased by adding isoosmolar buffer. To determine the optimal osmolarity, it is advisable to incubate the cells in different mixing ratios of hypo- and isoosmolar buffer for 30 minutes prior to the experiment (see Table 2).

This 30-minute period is the maximum incubation time for the cells in the electroporation buffer system. A new viability test followed by observation under a microscope determines the osmolarity that can be tolerated by the cells. The mixing concentrations can then be used for all subsequent experiments with this cell type.

Irrespective of the buffer system selected, it is essential to ensure that the cells do not remain in the electroporation buffer for longer than 30 minutes.

It is recommended to transfer the cells 510 minutes after the pulse into growth medium and incubate them for at least 23 hours at 37C before any centrifugation takes place. This step markedly increases the survival rate.

Desired osmolarity Eppendorf Hypoosmolar Buffer (ml) Eppendorf Isoosmolar Buffer (ml)
90 mOsmol/kg 10.0 0.0
150 mOsmol/kg 6.8 3.2
200 mOsmol/kg 4.2 5.8
250 mOsmol/kg 1.6 8.4
280 mOsmol/kg 0.0 10.0
Table 2.< /b> Volumes of Eppendorf Hypoosmolar and Isoosmolar Electroporation Buffers to be used to adjust the desired osmolarity (final volume: 10 ml).



Page: All 1 2 3 4 5

Related biology technology :

1. Optimizing Transfection Conditions for Studying Signal Transduction Pathways
2. Optimizing pfuturbo DNA Polymerase Amplification Reactions with Perfect Match PCR Enhancer
3. Optimizing electroporation parameters
4. Optimizing Büchi® Rotary Evaporator Applications
5. Optimizing electroporation parameters
6. Optimizing Büchi® Rotary Evaporator Applications
7. Optimizing Bchi Rotary Evaporator Applications
8. Optimizing electroporation parameters
9. Optimizing electroporation parameters
10. Optimizing electroporation parameters
11. Optimizing electroporation parameters
Post Your Comments:

(Date:11/25/2015)... DIEGO , Nov. 25, 2015  Neurocrine Biosciences, ... Kevin Gorman , President and CEO of Neurocrine Biosciences, ... Healthcare Conference in New York . ... to visit the website approximately 5 minutes prior to ... A replay of the presentation will be available on ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... company uBiome, were featured on AngelList early in their initial angel funding process. ... AngelList syndicate for individuals looking to make early stage investments in the microbiome ...
(Date:11/24/2015)... Nov. 24, 2015 /CNW/ - iCo Therapeutics ("iCo" or ... financial results for the quarter ended September 30, ... Canadian dollars and presented under International Financial Reporting ... ," said Andrew Rae , President ... iCo-008 are not only value enriching for this ...
(Date:11/24/2015)... , November 24, 2015 ... market research report "Oligonucleotide Synthesis Market by Product & ... Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & ... by MarketsandMarkets, the market is expected to reach USD ... 2015, at a CAGR of 10.1% during the forecast ...
Breaking Biology Technology:
(Date:11/17/2015)... Paris from 17 th ... Paris from 17 th until 19 th ... leader, has invented the first combined scanner in the world ... scanning surface. Until now two different scanners were required: one ... both on the same surface. This innovation is an ...
(Date:11/16/2015)... JOSE, Calif. , Nov 16, 2015 /PRNewswire/ ... developer of human interface solutions, today announced expansion ... Synaptics TouchView ™ touch controller and display ... architectural revolution of smartphones. These new TDDI products ... include TD4100 (HD resolution), TD4302 (WQHD resolution), and ...
(Date:11/11/2015)... MINNETONKA, Minn. , Nov. 11, 2015   MedNet ... the entire spectrum of clinical research, is pleased to announce ... Partnerships in Clinical Trials (PCT) event, to be held ... will be able to view live demonstrations of ... platform, and learn how iMedNet has been able ...
Breaking Biology News(10 mins):